ACTU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Actuate Therapeutics Inc (ACTU) is not a good buy for a beginner investor with a long-term focus at this time. The stock lacks positive catalysts, shows weak financial performance, and has no significant trading signals or momentum to suggest a strong entry point.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.455, with resistance at 2.795 and support at 2.115. Overall, the technical indicators do not suggest a strong buy signal.
NULL identified. No news or significant trading trends from hedge funds or insiders.
Weak financial performance with declining net income (-29.35% YoY) and EPS (-38.71% YoY). The stock also has a 70% chance of declining further in the short term (-2.08% next day, -0.59% next week, -8.04% next month).
In Q4 2025, revenue remained at 0 with no growth. Net income dropped significantly (-29.35% YoY), and EPS declined by -38.71% YoY. Gross margin remains at 0. Overall, the financials indicate poor performance and no growth.
No analyst rating or price target changes available.
